StonvexLoading…
StonvexStonvexStonvexCore line items from BLIN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $15.38M | $15.36M | $15.88M | $16.82M |
Operating Income | $-2.43M | $-2.02M | $-9.91M | $-1.90M |
Net Income | $-2.52M | $-1.96M | $-9.44M | $2.15M |
EPS (Diluted) | $-0.25 | $-0.19 | $-0.91 | $0.20 |
Total Assets | $15.33M | $15.60M | $17.63M | $27.51M |
Total Liabilities | $5.76M | $5.60M | $6.17M | $7.16M |
Cash & Equivalents | $1.63M | $1.39M | $2.38M | $2.86M |
Free Cash Flow OCF − CapEx | $-1.12M | $-794.00K | $252.00K | $-251.00K |
Shares Outstanding | 12.22M | 10.42M | 10.42M | 10.42M |